Pharmacists can improve hypertension care (but you have to pay them . . .): A review of remuneration opportunities across Canada.
作者信息
Chan Jonathan C, Tsuyuki Ross T
出版信息
Can Pharm J (Ott). 2020 Jan 15;153(1):7-8. doi: 10.1177/1715163519892207. eCollection 2020 Jan-Feb.
Abstract
摘要
相似文献
1
Pharmacists can improve hypertension care (but you have to pay them . . .): A review of remuneration opportunities across Canada.
Can Pharm J (Ott). 2020 Jan 15;153(1):7-8. doi: 10.1177/1715163519892207. eCollection 2020 Jan-Feb.
2
Pharmacists' perceptions of pay for performance versus fee-for-service remuneration for the management of hypertension through pharmacist prescribing.
Int J Pharm Pract. 2017 Oct;25(5):388-393. doi: 10.1111/ijpp.12330. Epub 2017 Jan 18.
3
Publicly funded remuneration for the administration of injections by pharmacists: An international review.
Can Pharm J (Ott). 2013 Nov;146(6):353-64. doi: 10.1177/1715163513506369.
4
A survey to assess the availability, implementation rate and remuneration of pharmacist-led cognitive services throughout Europe.
Res Social Adm Pharm. 2020 Jan;16(1):41-47. doi: 10.1016/j.sapharm.2019.02.002. Epub 2019 Feb 2.
5
Remunerated patient care services and injections by pharmacists: An international update.
J Am Pharm Assoc (2003). 2019 Jan-Feb;59(1):89-107. doi: 10.1016/j.japh.2018.07.002. Epub 2018 Sep 6.
6
AMCP Pay-for-Performance Principles: Performance-Based Reimbursement and Direct and Indirect Remuneration (DIR) Fees.
J Manag Care Spec Pharm. 2022 Feb;28(2):138-144. doi: 10.18553/jmcp.2022.28.2.138.
7
A comparative analysis of remuneration models for pharmaceutical professional services.
Health Policy. 2010 Apr;95(1):1-9. doi: 10.1016/j.healthpol.2009.11.008. Epub 2009 Nov 28.
8
Evaluation of job satisfaction among pharmacists working in public health facilities.
Explor Res Clin Soc Pharm. 2023 Sep 29;12:100338. doi: 10.1016/j.rcsop.2023.100338. eCollection 2023 Dec.
9
How can pharmacist remuneration systems in Europe contribute to generic medicine dispensing?
Pharm Pract (Granada). 2012 Jan;10(1):3-8. doi: 10.4321/s1886-36552012000100002. Epub 2012 Mar 31.
10
Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration.
Res Social Adm Pharm. 2020 Aug;16(8):1057-1066. doi: 10.1016/j.sapharm.2019.11.002. Epub 2019 Nov 7.
引用本文的文献
1
Do we need to separate pharmacy advocacy organizations?
Can Pharm J (Ott). 2024 May;157(3):99-100. doi: 10.1177/17151635241241039. Epub 2024 Apr 9.
2
The last 10 years of pharmacy practice, as told through editorials.
Can Pharm J (Ott). 2022 Dec 21;156(1):3-7. doi: 10.1177/17151635221144006. eCollection 2023 Jan-Feb.
本文引用的文献
1
A call to action to implement prescribing authority to pharmacists for hypertension management.
Can Pharm J (Ott). 2019 Jul 22;152(5):285-287. doi: 10.1177/1715163519866144. eCollection 2019 Sep-Oct.
2
Remunerated patient care services and injections by pharmacists: An international update.
Can Pharm J (Ott). 2019 Jan 24;152(2):92-108. doi: 10.1177/1715163518811065. eCollection 2019 Mar-Apr.
3
Pharmacist prescribing and care improves cardiovascular risk, but what do patients think? A substudy of the REACH study.
Can Pharm J (Ott). 2018 May 30;151(4):223-227. doi: 10.1177/1715163518779092. eCollection 2018 Jul-Aug.
4
Cost-effectiveness of pharmacist care for managing hypertension in Canada.
Can Pharm J (Ott). 2017 Mar 21;150(3):184-197. doi: 10.1177/1715163517701109. eCollection 2017 May-Jun.
5
Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).
Circulation. 2015 Jul 14;132(2):93-100. doi: 10.1161/CIRCULATIONAHA.115.015464. Epub 2015 Jun 10.
6
Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials.
J Am Heart Assoc. 2014 Apr 10;3(2):e000718. doi: 10.1161/JAHA.113.000718.
Zotero 插件